Arkolith/Insider Trading/SCPS/Form 4

Lamstein Joshua R

Chairman, DirectorScopus BioPharma Inc. (SCPS) · full profile →Form 4 · filed Aug 23, 2021
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2021Buy(P)800$4.04$3K120K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-108657) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML